Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.790
-0.140 (-7.25%)
At close: Feb 11, 2026, 4:00 PM EST
1.800
+0.010 (0.56%)
After-hours: Feb 11, 2026, 6:11 PM EST
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $321.57 million as of February 11, 2026. Its market cap has increased by 347.56% in one year.
Market Cap
321.57M
Enterprise Value
233.78M
1-Year Change
347.56%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $321.57M, a decrease of -69.40%. That is a compound annual growth rate of -22.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 321.57M | 270.22% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 379.79M |
| Entrada Therapeutics | 378.34M |
| Adlai Nortye | 373.43M |
| Aura Biosciences | 365.14M |
| Protara Therapeutics | 347.25M |
| Puma Biotechnology | 346.69M |
| Rocket Pharmaceuticals | 346.31M |
| Immix Biopharma | 338.31M |